What's Happening?
The Broadway production 'Every Brilliant Thing,' starring Daniel Radcliffe, has successfully recouped its $5.75 million investment. The play, which opened at the Hudson Theatre on March 12, achieved this financial milestone in less than two months, marking
it as one of the few productions of the 2025-2026 season to do so. The show benefits from Radcliffe's star power and interactive performance style, which includes engaging the audience in the narrative. The play's storyline revolves around a character who creates a list of brilliant things to uplift his mother, with audience members participating in the list's evolution. The production has maintained high ticket sales, with the week ending May 3 seeing a record $1.7 million in revenue. Radcliffe, who has been nominated for a Tony Award for his role, will perform his last show on May 24, after which Mariska Hargitay will take over the role until June 28.
Why It's Important?
The financial success of 'Every Brilliant Thing' underscores the significant impact of star power in Broadway productions. Daniel Radcliffe's involvement has not only attracted large audiences but also set a high benchmark for ticket sales, demonstrating the potential profitability of celebrity-driven shows. This success story is particularly notable in a season where many productions struggle to recoup investments. The play's achievement may encourage producers to invest in similar star-led projects, potentially reshaping the Broadway landscape by prioritizing productions with high-profile actors. Additionally, the show's interactive format and emotional narrative may influence future theatrical productions to incorporate more audience engagement and relatable themes.
What's Next?
Following Radcliffe's departure on May 24, Mariska Hargitay will assume the lead role, potentially attracting a new audience demographic and extending the show's successful run. The transition may also provide insights into the show's sustainability without its original star, offering a case study on the longevity of celebrity-driven productions. As the play continues, industry stakeholders will likely monitor its performance to gauge the impact of casting changes on ticket sales and audience reception. The show's ongoing success could further solidify its position as a model for future Broadway investments.
